Press Releases :: Wesana Health, Inc. (WESA)

Mar 22, 2022 7:30am EDT

Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Anti-Depressant

Mar 14, 2022 9:07am EDT

Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Mar 11, 2022 5:00pm EST

Wesana Provides Updates on Build-out of Third Clinic

Jan 25, 2022 7:30am EST

Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer

Jan 18, 2022 7:30am EST

Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol

Jan 12, 2022 7:00am EST

Wesana Health Provides Strategic and Operational Updates

Jan 11, 2022 7:00am EST

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Dec 14, 2021 7:32am EST

MAPS and Wesana Health Resume Negotiations

Dec 09, 2021 7:30am EST

Wesana Completes Filing of PCT Patents for Novel Drug Protocols

Nov 29, 2021 7:05pm EST

Wesana Health Reports Q3 2021 Financial Results

Previous
1
2
3
4
5
Next